EMFLAZA 18 mg/1
deflazacort · TABLET · PTC Therapeutics, Inc.
No Recall History
Plain English
Emflaza is an oral corticosteroid tablet used to treat Duchenne muscular dystrophy in patients age 5 and older. Each tablet contains 18 mg of deflazacort and requires a prescription.
Key Facts
- Brand Name
- EMFLAZA
- Generic Name
- deflazacort
- NDC Code (Product)
52856-502- Manufacturer
- PTC Therapeutics, Inc.
- Strength
- 18 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA208684
- Drug Class
- Corticosteroid [EPC]
- Marketing Start
- 09/10/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is EMFLAZA used for?
Emflaza is an oral corticosteroid tablet used to treat Duchenne muscular dystrophy in patients age 5 and older. Each tablet contains 18 mg of deflazacort and requires a prescription.
Is EMFLAZA a controlled substance?
EMFLAZA is not classified as a controlled substance by the DEA.
What is the generic name for EMFLAZA?
The generic name for EMFLAZA is deflazacort. There are 10 other brand versions of deflazacort.
What is the NDC code for EMFLAZA 18 mg/1?
The NDC (National Drug Code) for EMFLAZA 18 mg/1 is 52856-502, listed by PTC Therapeutics, Inc..